FindTrial
Sign In

The Comparision between the Yashtywha kadha basti treatment and tab febuxostat tratment in Gout patients.

A comparative clinical study to evaluate the effect of Yashtyawha kal basti and Tab. Febuxostat (40 mg BD) in Vatrakta w.s.r Gout - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094260
Enrollment
135
Registered
2025-09-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M100- Idiopathic gout

Interventions

None listed

Sponsors

Dr Anushri Vasant Netke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 2. Diagnosed Patients presenting with classical clinical features of Vatarakta. 3. Basti Yogya Patients 4. Increased sr. Uric acid levels more than 7mg/ dl in male and more than 6 mg/dl in female

Exclusion criteria

Exclusion criteria: 1. Pregnant Women and Lactating Mother 2. Hemorthrosis, Koch?s Arthritis, Septic Arthritis, Chronic Renal Failure, Severe Systemic Multi organ syndromes 3. Patient having any other systemic disorder viz. Diabetes Mellitus, Hypertension, abnormal liver enzymes etc. etc. 4. Basti Ayogya Patients 5. Patients with long standing use of corticosteroids 6. Gout with complications- joint damage, joint deformity, bone loss, tophi deposits etc.

Design outcomes

Primary

MeasureTime frame
The effect of Yashtywha kal basti and tab febuxostat 40 mg and combined effect of both treatment in Vatrakta w.s.r. GoutTimepoint: BASELINE,1ST, 16TH, 45TH—

Secondary

MeasureTime frame
? To evaluate the effect of Yashtyahwa Kal basti in the patients of vatrakta over a treatment period of 15 days. ? To evaluate the effect of Tab Febuxostat 40 mg BD in the patients of vatrakta over a treatment period of 15 days. ? To compare the clinical efficacy of Yashtyahwa Kal basti with Tab Febuxostat 40 mg BD in treatment of Vatrakta over a total duration of 45 days. ? To study the combined effect of Yashtyahwa Kal basti & Tab Febuxostat in Vatrakta over a total duration of 45 days. ? To observe the effect of the Yashtyahwa Kal basti, Tab Febuxostat & combination of both treatments on Sr. Uric acid levels, CRP & ESR on 0, 17th & 45th day. Timepoint: baseline,1st, 16th, 30th, 45th—

Countries

India

Contacts

Public ContactDr Anushri Vasant Netke

AYUSH

anetke939@gmail.com07038611626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026